Lyell Immunopharma Statistics
Total Valuation
LYEL has a market cap or net worth of $144.23 million. The enterprise value is -$128.81 million.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LYEL has 14.81 million shares outstanding. The number of shares has increased by 7.75% in one year.
| Current Share Class | 14.81M |
| Shares Outstanding | 14.81M |
| Shares Change (YoY) | +7.75% |
| Shares Change (QoQ) | +5.41% |
| Owned by Insiders (%) | 3.21% |
| Owned by Institutions (%) | 45.75% |
| Float | 9.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,218.93 |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/TBV Ratio | 0.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.49, with a Debt / Equity ratio of 0.17.
| Current Ratio | 7.49 |
| Quick Ratio | 7.30 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.20% and return on invested capital (ROIC) is -25.91%.
| Return on Equity (ROE) | -71.20% |
| Return on Assets (ROA) | -24.40% |
| Return on Invested Capital (ROIC) | -25.91% |
| Return on Capital Employed (ROCE) | -56.48% |
| Revenue Per Employee | $217 |
| Profits Per Employee | -$1.12M |
| Employee Count | 300 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.65% in the last 52 weeks. The beta is -0.27, so LYEL's price volatility has been lower than the market average.
| Beta (5Y) | -0.27 |
| 52-Week Price Change | -80.65% |
| 50-Day Moving Average | 9.05 |
| 200-Day Moving Average | 15.64 |
| Relative Strength Index (RSI) | 50.46 |
| Average Volume (20 Days) | 229,676 |
Short Selling Information
The latest short interest is 10.63 million, so 71.79% of the outstanding shares have been sold short.
| Short Interest | 10.63M |
| Short Previous Month | 9.71M |
| Short % of Shares Out | 71.79% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 16.43 |
Income Statement
In the last 12 months, LYEL had revenue of $65,000 and -$334.52 million in losses. Loss per share was -$24.63.
| Revenue | 65,000 |
| Gross Profit | 65,000 |
| Operating Income | -219.45M |
| Pretax Income | -210.26M |
| Net Income | -334.52M |
| EBITDA | -201.40M |
| EBIT | -219.45M |
| Loss Per Share | -$24.63 |
Full Income StatementBalance Sheet
The company has $301.18 million in cash and $57.09 million in debt, giving a net cash position of $273.04 million or $18.44 per share.
| Cash & Cash Equivalents | 301.18M |
| Total Debt | 57.09M |
| Net Cash | 273.04M |
| Net Cash Per Share | $18.44 |
| Equity (Book Value) | 336.52M |
| Book Value Per Share | 22.79 |
| Working Capital | 267.89M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$175.12 million and capital expenditures -$680,000, giving a free cash flow of -$175.80 million.
| Operating Cash Flow | -175.12M |
| Capital Expenditures | -680,000 |
| Free Cash Flow | -175.80M |
| FCF Per Share | -$11.87 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -337,613.85% |
| Pretax Margin | -514,649.23% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.75% |
| Shareholder Yield | -7.75% |
| Earnings Yield | -231.94% |
| FCF Yield | -121.89% |
Analyst Forecast
The average price target for LYEL is $20.00, which is 101.92% higher than the current price. The consensus rating is "Sell".
| Price Target | $20.00 |
| Price Target Difference | 101.92% |
| Analyst Consensus | Sell |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
LYEL has an Altman Z-Score of -3.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.18 |
| Piotroski F-Score | 1 |